Yep..This is by and far the lowest float stock at these prices, shares hard to buy and huge demand due to CANCER - Immunotherapy play involved here. This will be at 0.1 in a couple of weeks. Too much demand and less supply - ZERO dilution..
Worldwide thing was the game changer event here
That was it
expect JV - and now Europe and Latin America/India wide open for quick and fast trials. They will launch trials through JV, that's why they acquired world wide rights..No other reason
if you have invested in other CANCER biotechs (small and micro) you will know, most do trials are done worldwide first through JV. I know many have done, GALE did through India, ADXS did through india - It was penny stock. BTW - ADXS, now has 400 million market cap..
same pattern here
Both these were penny stocks earlier.
That is why this is going up, add to that zero dilution..shares are hard to buy..This will be at 10 million market cap in couple of weeks. If we get NEWS, this will just fly
No downside - Huge upside
forget all those sub-penny prices, it as at sub-penny because they had only USA rights where costs are high and FDA approval is hard. Now all that changed
see no one is selling the shares..huge accumulation going on
No resistance till 0.03 now
Market Data 
Markets 
AI
